文献速递肝病

PNPLA3基因变异与膳食摄入对NAFLD显著纤维化风险的交互影响

Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

本研究在452例经组织学确诊的非西班牙裔白人NAFLD患者中,探讨PNPLA3 rs738409基因型与营养素摄入对纤维化严重程度的交互作用。结果显示高碳水摄入与显著纤维化风险正相关,而n-3多不饱和脂肪酸、异黄酮、蛋氨酸和胆碱摄入呈负相关,且这些关联仅在G等位基因携带者中显著,提示基因-膳食交互影响纤维化风险。

要点

  • PNPLA3 rs738409 G等位基因携带者中,高碳水摄入增加显著纤维化风险。
  • n-3多不饱和脂肪酸、异黄酮、蛋氨酸和胆碱摄入与显著纤维化风险降低相关。
  • 膳食因素对纤维化的影响在G等位基因携带者中更显著,呈基因型依赖。

核心结论

  • PNPLA3 rs738409 G等位基因可能调节特定膳食营养素对NAFLD患者纤维化风险的影响。

研究设计与样本

  • 在452例经组织学确诊的NAFLD非西班牙裔白人患者中,对PNPLA3 rs738409进行基因分型,并使用食物频率问卷评估营养素摄入,以肝组织学纤维化严重程度为结局。

主要发现

  • 高碳水摄入(占每日能量百分比)与显著纤维化风险正相关(Adj OR: 1.03, P < 0.01)。
  • n-3多不饱和脂肪酸(g/d)(Adj OR: 0.17, P < 0.01)、异黄酮(mg/d)(Adj OR: 0.74, P = 0.049)、蛋氨酸(mg/d)(Adj OR: 0.32, P < 0.01)和胆碱(mg/d)(Adj OR: 0.32, P < 0.01)摄入与显著纤维化风险负相关。
  • 在加性遗传模型下,PNPLA3 rs738409以剂量依赖的基因型方式显著调节碳水化合物(%)、n-3多不饱和脂肪酸、总异黄酮、蛋氨酸和胆碱摄入与纤维化严重程度的关系,这些膳食因素在G等位基因携带者中效应更大且显著。
  • 仅在rs738409 G等位基因携带者中,显著纤维化与碳水化合物(Adj OR: 1.04, P = 0.019)、n-3多不饱和脂肪酸(Adj OR: 0.16, P < 0.01)、异黄酮(Adj OR: 0.65, P = 0.025)、蛋氨酸(Adj OR: 0.30, P < 0.01)和总胆碱(Adj OR: 0.29, P < 0.01)摄入的关联仍显著。

临床怎么用

  • 对于NAFLD患者,尤其是PNPLA3 rs738409 G等位基因携带者,可考虑评估膳食摄入并针对性调整营养素以降低纤维化风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study explored the relationship between patatin-like phospholipase domain-containing 3 gene (PNPLA3 rs738409), nutrient intake, and liver histology severity in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: PNPLA3-rs738409 variant was genotyped in 452 non-Hispanic whites with histologically confirmed NAFLD who completed Food Frequency Questionnaire within 6 months of their liver biopsy. The fibrosis severity on liver histology was the outcome of interest. RESULTS: The distribution of PNPLA3 genotypes was CC: 28%, CG: 46%, and GG: 25%. High-carbohydrate (% of energy/d) intake was positively associated (adjusted [Adj] odds ratio [OR]: 1.03, P < 0.01), whereas higher n-3 polyunsaturated fatty acids (n-3 PUFAs) (g/d) (Adj. OR: 0.17, P < 0.01), isoflavones (mg/d) (Adj. OR: 0.74, P = 0.049), methionine (mg/d) (Adj. OR: 0.32, P < 0.01), and choline (mg/d) (Adj. OR: 0.32, P < 0.01) intakes were inversely associated with increased risk of significant fibrosis (stage of fibrosis ≥2). By using an additive model of inheritance, our moderation analysis showed that PNPLA3 rs738409 significantly modulates the relationship between carbohydrate (%), n-3 PUFAs, total isoflavones, methionine, and choline intakes and fibrosis severity in a dose-dependent, genotype manner. These dietary factors tended to have a larger and significant effect on fibrosis severity among rs738409 G-allele carriers. Associations between significant fibrosis and carbohydrates (Adj. OR: 1.04, P = 0.019), n-3 PUFAs (Adj. OR: 0.16, P < 0.01), isoflavones (Adj. OR: 0.65, P = 0.025), methionine (Adj. OR: 0.30, P < 0.01), and total choline (Adj. OR: 0.29, P < 0.01) intakes remained significant only among rs738409 G-allele carriers. DISCUSSION: This gene-diet interaction study suggests that PNPLA3 rs738409 G-allele might modulate the effect of specific dietary nutrients on risk of fibrosis in patients with NAFLD.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Vilar-Gomez E, Pirola CJ, Sookoian S, et al. Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD. Am J Gastroenterol. 2021. PMID: 33306506. doi:10.14309/ajg.0000000000001072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。